New CAS in Advanced Therapy Medicinal Products (ATMPs)
INTRODUCTION
Advanced therapy medicinal products (ATMPs) such as cell therapy, tissue-engineered medicine or immunotherapy, as well as innovative medicines like phage therapy or nanomedicine, are pushing the boundaries of currently available treatments. Oncology, reconstructive surgery, orthopaedic surgery, neurosurgery, blood transfusion, infectious diseases – clinical applications are numerous.
Providing healthcare professionals with a thorough understanding of these therapeutic breakthroughs is essential to ensure the effective transition of these innovative treatments and care techniques from the bench to the bedside.
TARGET AUDIENCE
Healthcare professionals and scientists interested in the emerging field of advanced therapies, including pharmacists, physicians, medical researchers, biologists, healthcare engineers, biostatisticians
REGISTRATION DEADLINE
August 21, 2023
Number of participants is limited
CONTACT
Dr. Michele Graciotti, Programme coordinator; Project Manager, Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital and UNIL
